Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 10/2013

01.10.2013 | Genetics

The association between thrombophilic gene mutations and recurrent pregnancy loss

verfasst von: Ahmad Poursadegh Zonouzi, Nader Chaparzadeh, Saeid Ghorbian, Mahzad Mehrzad Sadaghiani, Laya Farzadi, Alieh Ghasemzadeh, Taiebeh Kafshdooz, Masoud Sakhinia, Ebrahim Sakhinia

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine whether the Factor V (1691G/A), Factor V HR2 (4070A/G), Prothrombin (20210G/A), PAI-1 (-675 I/D, 5G/4G), ACE (intron 16 I/D), Factor VII (Gln353Arg), Factor XIII (Val34Leu), β-fibrinogen (-455G/A), Glycoprotein Ia (807C/T), tPA (intron 8 D/I) gene mutations could be risk factors for recurrent pregnancy loss (RPL).

Methods

Genotyping of thrombophilic gene mutations were carried out by amplification Refractory Mutation System-PCR (ARMS-PCR) method after DNA extraction.

Results

We found that the mutant allele frequencies of Factor V (1691G/A), Factor V HR2 (4070A/G), Prothrombin (20210G/A), PAI-1 (-675 I/D, 5G/4G), Factor XIII (Val34Leu) and β-fibrinogen (-455G/A) were more seen in the case group compared with the healthy control; However, the difference between the two group is not statistically significant (p > 0.05). Whilst the mutant allele frequencies of other studied genes were lower in the case in comparison to the fertile control women (p > 0.05).

Conclusion

Taken together, our data has shown that the prevalence of thrombophilic gene mutations was similar in women with RPL and healthy controls. Therefore, it appears that further studies on large-scale population and other genetic variants will be needed to conclusively find candidate genes for RPL unknown etiology in the future.
Literatur
1.
Zurück zum Zitat Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes. 2009;16:446–50.PubMedCrossRef Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes. 2009;16:446–50.PubMedCrossRef
2.
Zurück zum Zitat Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007;86:727–31.PubMedCrossRef Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007;86:727–31.PubMedCrossRef
3.
Zurück zum Zitat Berthold H, Guido AH, Jorgen K, Peter H, Holger K, Abdulgabar S. Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system. Thromb Res. 2003;111:115–20.CrossRef Berthold H, Guido AH, Jorgen K, Peter H, Holger K, Abdulgabar S. Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system. Thromb Res. 2003;111:115–20.CrossRef
4.
Zurück zum Zitat Bloomenthal D, Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002;167:48–54.PubMedPubMedCentral Bloomenthal D, Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002;167:48–54.PubMedPubMedCentral
5.
Zurück zum Zitat Bom JG, Knijff P, Haverkate F, Bots ML, Meijer P, deJong PTVM, et al. Tissue plasminogen activator and risk of myocardial infarction. Circulation. 1997;95:2623–7.PubMedCrossRef Bom JG, Knijff P, Haverkate F, Bots ML, Meijer P, deJong PTVM, et al. Tissue plasminogen activator and risk of myocardial infarction. Circulation. 1997;95:2623–7.PubMedCrossRef
6.
Zurück zum Zitat Brandt JT. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med. 2002;126:1376–81.PubMed Brandt JT. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med. 2002;126:1376–81.PubMed
7.
Zurück zum Zitat Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000;7:284–9.PubMedCrossRef Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000;7:284–9.PubMedCrossRef
8.
Zurück zum Zitat Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ. Polymorphisms in the ACE and PAI -1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod. 2003;18:2473–7.PubMedCrossRef Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ. Polymorphisms in the ACE and PAI -1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod. 2003;18:2473–7.PubMedCrossRef
9.
Zurück zum Zitat Carp H, Salomon O, Seidman D. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002;17:1633–7.PubMedCrossRef Carp H, Salomon O, Seidman D. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002;17:1633–7.PubMedCrossRef
10.
Zurück zum Zitat Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood. 2000;96:1443–8.PubMed Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood. 2000;96:1443–8.PubMed
11.
Zurück zum Zitat Cleary-Goldman J, Nakhuda GS, Zimmermann RC, Sauer MV. The role of factor V Leiden mutation in recurrent pregnancy loss. J Am Med Wom Assoc. 2003;58:165–72.PubMed Cleary-Goldman J, Nakhuda GS, Zimmermann RC, Sauer MV. The role of factor V Leiden mutation in recurrent pregnancy loss. J Am Med Wom Assoc. 2003;58:165–72.PubMed
12.
Zurück zum Zitat Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006;55:360–8.PubMedCrossRef Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006;55:360–8.PubMedCrossRef
13.
Zurück zum Zitat Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol. 2008;60:426–31.PubMedCrossRef Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol. 2008;60:426–31.PubMedCrossRef
14.
Zurück zum Zitat Dawood F, Mountford R, Farquharson R, Quenby S. Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR. Hum Reprod. 2007;22:2546–53.PubMedCrossRef Dawood F, Mountford R, Farquharson R, Quenby S. Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR. Hum Reprod. 2007;22:2546–53.PubMedCrossRef
15.
Zurück zum Zitat Dossenbach-Glaninger A, Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem. 2003;49:1081–6.PubMedCrossRef Dossenbach-Glaninger A, Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem. 2003;49:1081–6.PubMedCrossRef
16.
Zurück zum Zitat Dunne FM, Doggen CJ, Heemskerk M, Rosendaal FR, Helmerhorst FM. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod. 2005;20:802–6.PubMedCrossRef Dunne FM, Doggen CJ, Heemskerk M, Rosendaal FR, Helmerhorst FM. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod. 2005;20:802–6.PubMedCrossRef
17.
Zurück zum Zitat Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2:76–83.PubMedPubMedCentral Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2:76–83.PubMedPubMedCentral
18.
Zurück zum Zitat Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V. Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol. 2002;102:111–9.PubMedCrossRef Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V. Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol. 2002;102:111–9.PubMedCrossRef
19.
Zurück zum Zitat Ghee CB, Burrows RF. Prothrombin G20210A mutation is not associated with recurrent miscarriages. Aust N Z J Obstet Gynaecol. 2002;42:167–9.PubMedCrossRef Ghee CB, Burrows RF. Prothrombin G20210A mutation is not associated with recurrent miscarriages. Aust N Z J Obstet Gynaecol. 2002;42:167–9.PubMedCrossRef
20.
Zurück zum Zitat Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol. 2006;56:230–6.PubMedCrossRef Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol. 2006;56:230–6.PubMedCrossRef
21.
Zurück zum Zitat Goodman C, Hur J, Goodman CS, Jeyendran RS, Coulam C. Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? Am J Reprod Immunol. 2009;62:365–70.PubMedCrossRef Goodman C, Hur J, Goodman CS, Jeyendran RS, Coulam C. Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? Am J Reprod Immunol. 2009;62:365–70.PubMedCrossRef
22.
Zurück zum Zitat Gumpel C, Fornasiero L, Suarez S, Santillan G, Colabianchi J. PAI- 1 4G⁄ 5G polymorphism detection and obstetric complications. Thromb Res. 2009;123:S148.CrossRef Gumpel C, Fornasiero L, Suarez S, Santillan G, Colabianchi J. PAI- 1 4G⁄ 5G polymorphism detection and obstetric complications. Thromb Res. 2009;123:S148.CrossRef
23.
Zurück zum Zitat Hashimoto K, Shizusawa Y, Shimoya K. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod. 1999;14:1872–4.PubMedCrossRef Hashimoto K, Shizusawa Y, Shimoya K. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod. 1999;14:1872–4.PubMedCrossRef
24.
Zurück zum Zitat Humphries SE, Cook M, Dubovitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1:1452–5.PubMedCrossRef Humphries SE, Cook M, Dubovitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1:1452–5.PubMedCrossRef
25.
Zurück zum Zitat Jaleh Z, Mozhdeh M, Khatereh A, Fariborz G, Zohreh T. The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol. 2011;155:217–20.CrossRef Jaleh Z, Mozhdeh M, Khatereh A, Fariborz G, Zohreh T. The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol. 2011;155:217–20.CrossRef
26.
Zurück zum Zitat Jeddi-Tehrani M, Torabi R, Zarnani AH, Mohammadzadeh A, Arefi S, Zeraati H, et al. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Am J Reprod Immunol. 2011;66:149–56.PubMedCrossRef Jeddi-Tehrani M, Torabi R, Zarnani AH, Mohammadzadeh A, Arefi S, Zeraati H, et al. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Am J Reprod Immunol. 2011;66:149–56.PubMedCrossRef
28.
Zurück zum Zitat Marty S, Barro C, Chatelain B, Fimbel B, Tribout B, Reynaud J, et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia. 2008;14:564–70.PubMedCrossRef Marty S, Barro C, Chatelain B, Fimbel B, Tribout B, Reynaud J, et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia. 2008;14:564–70.PubMedCrossRef
29.
Zurück zum Zitat Meka A, Reddy BM. Recurrent spontaneous abortions: an overview of genetic and non-genetic backgrounds. Int J Hum Genet. 2006;6:109–17. Meka A, Reddy BM. Recurrent spontaneous abortions: an overview of genetic and non-genetic backgrounds. Int J Hum Genet. 2006;6:109–17.
30.
Zurück zum Zitat Okumus G, Kiyan E, Arseven O, Tabak L, Bayrak EK, Unaltuna NE, et al. Platelet glycoprotein ia 807c/t and 873g/a polymorphisms in patients with venous thromboembolism. Clin Appl Thromb Hemost. 2007;13:101–3.PubMedCrossRef Okumus G, Kiyan E, Arseven O, Tabak L, Bayrak EK, Unaltuna NE, et al. Platelet glycoprotein ia 807c/t and 873g/a polymorphisms in patients with venous thromboembolism. Clin Appl Thromb Hemost. 2007;13:101–3.PubMedCrossRef
31.
Zurück zum Zitat Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005;272:95–108.PubMedCrossRef Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005;272:95–108.PubMedCrossRef
32.
Zurück zum Zitat Reiner AP, Siscovick DS, Rosendaal FR. Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol. 2001;5:262–87.PubMedCrossRef Reiner AP, Siscovick DS, Rosendaal FR. Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol. 2001;5:262–87.PubMedCrossRef
33.
Zurück zum Zitat Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughn DE. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (TPA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol. 1997;17:1687–90.PubMed Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughn DE. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (TPA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol. 1997;17:1687–90.PubMed
34.
Zurück zum Zitat Rousseau F, Rehel R, Rouillard P, DeGranpre P, Khandjian EW. High throughput and economical mutation detection and RFLP analysis using a minimethod for DNA preparation from whole blood and acrylamide gel electrophoresis. Hum Mutat. 1994;4:51–4.PubMedCrossRef Rousseau F, Rehel R, Rouillard P, DeGranpre P, Khandjian EW. High throughput and economical mutation detection and RFLP analysis using a minimethod for DNA preparation from whole blood and acrylamide gel electrophoresis. Hum Mutat. 1994;4:51–4.PubMedCrossRef
35.
Zurück zum Zitat Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the Mediterranean population. Arch Gynecol Obstet. 2005;273:170–3.PubMedCrossRef Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the Mediterranean population. Arch Gynecol Obstet. 2005;273:170–3.PubMedCrossRef
36.
Zurück zum Zitat Seremak-Mrozikiewicz A, Drews K, Kurzawińska G, Barlik M, Mrozikiewicz PM. The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages. Ginekol Pol. 2009;80:8–13.PubMed Seremak-Mrozikiewicz A, Drews K, Kurzawińska G, Barlik M, Mrozikiewicz PM. The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages. Ginekol Pol. 2009;80:8–13.PubMed
37.
Zurück zum Zitat Steeds R, Adams M, Smith P, Channer K, Samani NJ. Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb Haemost. 1998;79:980–4.PubMed Steeds R, Adams M, Smith P, Channer K, Samani NJ. Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb Haemost. 1998;79:980–4.PubMed
38.
Zurück zum Zitat Subrt I, Ulcova-Gallova Z, Cerna M, Hejnalova M, Slovanova J, Bibkova K, et al. Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women. Am J Reprod Immunol. 2013. doi:10.1111/aji.12099.PubMed Subrt I, Ulcova-Gallova Z, Cerna M, Hejnalova M, Slovanova J, Bibkova K, et al. Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women. Am J Reprod Immunol. 2013. doi:10.​1111/​aji.​12099.PubMed
40.
Zurück zum Zitat Yenicesu I, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, et al. A prospective case–control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010;63:126–36.PubMedCrossRef Yenicesu I, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, et al. A prospective case–control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010;63:126–36.PubMedCrossRef
Metadaten
Titel
The association between thrombophilic gene mutations and recurrent pregnancy loss
verfasst von
Ahmad Poursadegh Zonouzi
Nader Chaparzadeh
Saeid Ghorbian
Mahzad Mehrzad Sadaghiani
Laya Farzadi
Alieh Ghasemzadeh
Taiebeh Kafshdooz
Masoud Sakhinia
Ebrahim Sakhinia
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 10/2013
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-013-0071-5

Weitere Artikel der Ausgabe 10/2013

Journal of Assisted Reproduction and Genetics 10/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.